Rigel Pharmaceuticals, Inc. (RIGL) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Rigel Pharmaceuticals, Inc. (RIGL)

An SI Board Since November 2000

Posts	SubjectMarks	Bans	Symbol
566	39	0	RIGL

Emcee: scaram(o)uche	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
166	HCV was mid-November. Nothing that I can see.	mopgcw	-	12/5/2003
165	InvestBio had a big whoop in San Francisco tonight. Maybe the Garren road show	scaram(o)uche	-	12/4/2003
164	RIGL has been on a tear the last couple days -- barely misses fireworks status t	mopgcw	-	12/3/2003
163	<i> Where were they when the market cap was about the price of a beer? Was	mopgcw	-	11/17/2003
162	>> but these reports do provide interesting metrics to think about and som	scaram(o)uche	-	11/17/2003
161	Especially considering where RIGL was trading not too long ago..on the devil'	mopgcw	-	11/17/2003
160	>> We believe that its hepatitis C small molecule program alone is worth m	scaram(o)uche	-	11/17/2003
159	>>HCV: Current Treatments and Market Opportunity Hepatitis C is an inflam	tuck	-	11/12/2003
158	>>SOUTH SAN FRANCISCO, Calif., Nov. 12 /PRNewswire-FirstCall/ -- Rigel Pha	tuck	-	11/12/2003
157	CSFB Report from a Yahoo post: We initiate coverage of Rigel at Outperform and	mopgcw	-	11/10/2003
156	Coverage by CSFB? Good Heavens. Hope they know something. Edit: Just checked	keokalani'nui	-	11/7/2003
155	From Briefing.com: >>9:14AM Rigel Pharms started with an Outperform at CS	tuck	-	11/7/2003
154	Rigel to Host Hepatitis C Investor Briefing on November 19, 2003 Thursday Novemb	nigel bates	-	11/6/2003
153	RIGL's quarterly PR, with no CC, and somewhat vague pipeline update. Is it	tuck	-	11/5/2003
152	The RIGL pr - SOUTH SAN FRANCISCO, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Rig	nigel bates	-	11/3/2003
151	Chiron Grants Nonexclusive HCV License to Rigel Pharmaceuticals EMERYVILLE, Cal	nigel bates	-	11/3/2003
150	>>Chem Biol. 2003 Oct;10(10):975-87. Cellular localization and antiprol	tuck	-	10/30/2003
149	>>SOUTH SAN FRANCISCO, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Rigel Pha	tuck	-	10/27/2003
148	Discovery of Peptides with Anti-Proliferative Effects 2003-10-20 07:30 (New York	mopgcw	-	10/20/2003
147	Full text article (might require free registration) on Rigel's pathway mappi	tuck	-	10/15/2003
146	Rigel Pharmaceuticals Appoints Robin Cooper, Ph.D., D.Sc., Senior Vice President	mopgcw	-	10/7/2003
145	Rigel Pharmaceuticals to Present at UBS Warburg Conference on September 22 Th	mopgcw	-	9/18/2003
144	Rigel Team Discovers New Regulators of the Immune System Monday September 15, 7:	nigel bates	-	9/15/2003
143	who else is slowly taking profits on their over allotment here? it does salve t	mopgcw	-	9/10/2003
142	Rigel Initiates Multi-Dose Safety Trial of R112 for Allergic Rhinitis Wednesday	keokalani'nui	-	9/10/2003

Go to reply# or date (mm/dd/yy):